AusCann Group Holdings Ltd (ASX: AC8) is engaged in manufacturing and offering clinically validated cannabinoid medicines and aims to assist Australian patients in every regard. It has operations that run through different phases like cultivation and production, manufacture and distribution of products. The group was earlier known as TW Holdings Limited, and has been into cannabis cultivation for quite some time. They started with medications for neuropathic and chronic pain and have been targeting the opportunity in Australia primarily ($9 billion).
Join Investment Event